Details for New Drug Application (NDA): 215566
✉ Email this page to a colleague
The generic ingredient in CLORAZEPATE DIPOTASSIUM is clorazepate dipotassium. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
Summary for 215566
Tradename: | CLORAZEPATE DIPOTASSIUM |
Applicant: | Corepharma |
Ingredient: | clorazepate dipotassium |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 215566
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 215566 | ANDA | Apotex Corp. | 60505-4754 | 60505-4754-1 | 100 mg in 1 BOTTLE (60505-4754-1) |
CLORAZEPATE DIPOTASSIUM | clorazepate dipotassium | TABLET;ORAL | 215566 | ANDA | Apotex Corp. | 60505-4755 | 60505-4755-1 | 100 mg in 1 BOTTLE (60505-4755-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 3.75MG | ||||
Approval Date: | Jun 14, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
Approval Date: | Jun 14, 2022 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
Approval Date: | Jun 14, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription